These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37888205)

  • 1. Inverse Modulation of Aurora Kinase A and Topoisomerase IIα in Normal and Tumor Breast Cells upon Knockdown of Mitochondrial ASncmtRNA.
    Bendek MF; Fitzpatrick C; Jeldes E; Boland A; Deleuze JF; Farfán N; Villegas J; Nardocci G; Montecino M; Burzio LO; Burzio VA
    Noncoding RNA; 2023 Oct; 9(5):. PubMed ID: 37888205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial ncRNA targeting induces cell cycle arrest and tumor growth inhibition of MDA-MB-231 breast cancer cells through reduction of key cell cycle progression factors.
    Fitzpatrick C; Bendek MF; Briones M; Farfán N; Silva VA; Nardocci G; Montecino M; Boland A; Deleuze JF; Villegas J; Villota C; Silva V; Lobos-Gonzalez L; Borgna V; Barrey E; Burzio LO; Burzio VA
    Cell Death Dis; 2019 May; 10(6):423. PubMed ID: 31142736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of the antisense mitochondrial non-coding RNAs (ncRNAs) is a unique vulnerability of cancer cells and a potential target for cancer therapy.
    Vidaurre S; Fitzpatrick C; Burzio VA; Briones M; Villota C; Villegas J; Echenique J; Oliveira-Cruz L; Araya M; Borgna V; Socías T; Lopez C; Avila R; Burzio LO
    J Biol Chem; 2014 Sep; 289(39):27182-27198. PubMed ID: 25100722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense noncoding mitochondrial RNA-2 gives rise to miR-4485-3p by Dicer processing in vitro.
    Farfán N; Sanhueza N; Briones M; Burzio LO; Burzio VA
    Biol Res; 2021 Oct; 54(1):33. PubMed ID: 34666824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo knockdown of antisense non-coding mitochondrial RNAs by a lentiviral-encoded shRNA inhibits melanoma tumor growth and lung colonization.
    Varas-Godoy M; Lladser A; Farfan N; Villota C; Villegas J; Tapia JC; Burzio LO; Burzio VA; Valenzuela PDT
    Pigment Cell Melanoma Res; 2018 Jan; 31(1):64-72. PubMed ID: 28707763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes released upon mitochondrial ASncmtRNA knockdown reduce tumorigenic properties of malignant breast cancer cells.
    Lobos-González L; Bustos R; Campos A; Silva V; Silva V; Jeldes E; Salomon C; Varas-Godoy M; Cáceres-Verschae A; Duran E; Vera T; Ezquer F; Ezquer M; Burzio VA; Villegas J
    Sci Rep; 2020 Jan; 10(1):343. PubMed ID: 31941923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV-18 E2 protein downregulates antisense noncoding mitochondrial RNA-2, delaying replicative senescence of human keratinocytes.
    Villota C; Varas-Godoy M; Jeldes E; Campos A; Villegas J; Borgna V; Burzio LO; Burzio VA
    Aging (Albany NY); 2018 Dec; 11(1):33-47. PubMed ID: 30595560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting antisense mitochondrial ncRNAs inhibits murine melanoma tumor growth and metastasis through reduction in survival and invasion factors.
    Lobos-González L; Silva V; Araya M; Restovic F; Echenique J; Oliveira-Cruz L; Fitzpatrick C; Briones M; Villegas J; Villota C; Vidaurre S; Borgna V; Socias M; Valenzuela S; Lopez C; Socias T; Varas M; Díaz J; Burzio LO; Burzio VA
    Oncotarget; 2016 Sep; 7(36):58331-58350. PubMed ID: 27507060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
    Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial ASncmtRNA-1 and ASncmtRNA-2 as potent targets to inhibit tumor growth and metastasis in the RenCa murine renal adenocarcinoma model.
    Borgna V; Villegas J; Burzio VA; Belmar S; Araya M; Jeldes E; Lobos-González L; Silva V; Villota C; Oliveira-Cruz L; Lopez C; Socias T; Castillo O; Burzio LO
    Oncotarget; 2017 Jul; 8(27):43692-43708. PubMed ID: 28620146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNAs: From disease code to drug role.
    Chen Y; Li Z; Chen X; Zhang S
    Acta Pharm Sin B; 2021 Feb; 11(2):340-354. PubMed ID: 33643816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
    Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of mitochondrial non-coding RNAs (ncRNAs) is modulated by high risk human papillomavirus (HPV) oncogenes.
    Villota C; Campos A; Vidaurre S; Oliveira-Cruz L; Boccardo E; Burzio VA; Varas M; Villegas J; Villa LL; Valenzuela PD; Socías M; Roberts S; Burzio LO
    J Biol Chem; 2012 Jun; 287(25):21303-15. PubMed ID: 22539350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mitochondrial lncRNA ASncmtRNA-2 is induced in aging and replicative senescence in Endothelial Cells.
    Bianchessi V; Badi I; Bertolotti M; Nigro P; D'Alessandra Y; Capogrossi MC; Zanobini M; Pompilio G; Raucci A; Lauri A
    J Mol Cell Cardiol; 2015 Apr; 81():62-70. PubMed ID: 25640160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-treatment with vorinostat synergistically enhances activity of Aurora kinase inhibitor against human breast cancer cells.
    Fiskus W; Hembruff SL; Rao R; Sharma P; Balusu R; Venkannagari S; Smith JE; Peth K; Peiper SC; Bhalla KN
    Breast Cancer Res Treat; 2012 Sep; 135(2):433-44. PubMed ID: 22825030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol inhibits cell cycle progression by targeting Aurora kinase A and Polo-like kinase 1 in breast cancer cells.
    Medina-Aguilar R; Marchat LA; Arechaga Ocampo E; Gariglio P; García Mena J; Villegas Sepúlveda N; Martínez Castillo M; López-Camarillo C
    Oncol Rep; 2016 Jun; 35(6):3696-704. PubMed ID: 27109433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoprotegerin secreted by inflammatory and invasive breast cancer cells induces aneuploidy, cell proliferation and angiogenesis.
    Goswami S; Sharma-Walia N
    BMC Cancer; 2015 Nov; 15():935. PubMed ID: 26608463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense imaging of epidermal growth factor-induced p21(WAF-1/CIP-1) gene expression in MDA-MB-468 human breast cancer xenografts.
    Wang J; Chen P; Mrkobrada M; Hu M; Vallis KA; Reilly RM
    Eur J Nucl Med Mol Imaging; 2003 Sep; 30(9):1273-80. PubMed ID: 12640557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cell cycle-related genes RHAMM, AURKA, TPX2, PLK1, and PLK4 are associated with the poor prognosis of breast cancer patients.
    Kahl I; Mense J; Finke C; Boller AL; Lorber C; Győrffy B; Greve B; Götte M; Espinoza-Sánchez NA
    J Cell Biochem; 2022 Mar; 123(3):581-600. PubMed ID: 35014077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selective effect of glycyrrhizin and glycyrrhetinic acid on topoisomerase IIα and apoptosis in combination with etoposide on triple negative breast cancer MDA-MB-231 cells.
    Cai Y; Zhao B; Liang Q; Zhang Y; Cai J; Li G
    Eur J Pharmacol; 2017 Aug; 809():87-97. PubMed ID: 28506909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.